Pharmaceutical companies put focus on technically feasible technologies

Published: 2004-01-20 07:00:00

Updated: 2004-01-20 07:00:00

Shaking off the severe slump last year and promoting export drive in future, major pharmaceutical firms said in their 2004 first-generic strategies that they would target higher sales growth this year within a short period of time by developing wider range of new chemical drug entities and severa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK